HEART-LUNG TRANSPLANTATION

Slides:



Advertisements
Similar presentations
HEART TRANSPLANTATION
Advertisements

HEART-LUNG TRANSPLANTATION Overall ISHLT 2006 J Heart Lung Transplant 2006;25:
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2006 J Heart Lung Transplant 2006;25:
HEART-LUNG TRANSPLANTATION Overall ISHLT 2005 J Heart Lung Transplant 2005;24:
HEART TRANSPLANTATION Overall ISHLT 2008 J Heart Lung Transplant 2008;27:
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2006 J Heart Lung Transplant 2006;25:
2004 ISHLT J Heart Lung Transplant 2004; 23: HEART-LUNG TRANSPLANTATION Overall.
J Heart Lung Transplant 2009;28: HEART TRANSPLANTATION Overall ISHLT 2009.
J Heart Lung Transplant 2009;28: HEART TRANSPLANTATION Pediatric Recipients ISHLT 2009.
HEART-LUNG TRANSPLANTATION
LUNG TRANSPLANTATION Pediatric Recipients 2011 ISHLT J Heart Lung Transplant Oct; 30 (10):
HEART-LUNG TRANSPLANTATION Overall ISHLT 2008 J Heart Lung Transplant 2008;27:
HEART TRANSPLANTATION Pediatric Recipients 2010 ISHLT J Heart Lung Transplant Oct; 29 (10):
HEART TRANSPLANTATION
HEART-LUNG TRANSPLANTATION Overall 2010 ISHLT J Heart Lung Transplant Oct; 29 (10):
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26:
HEART-LUNG TRANSPLANTATION
2004 ISHLT J Heart Lung Transplant 2004; 23: HEART TRANSPLANTATION Overall.
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2008 J Heart Lung Transplant 2008;27:
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26.
HEART-LUNG TRANSPLANTATION
HEART TRANSPLANTATION Adult Recipients JHLT Oct; 32(10):
HEART-LUNG TRANSPLANTATION Overall 2014 JHLT Oct; 33(10):
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
Optimizing lung transplant outcomes in the adult and pediatric patient. Cynthia S. Herrington, MD Associate Professor of Surgery Keck School of Medicine.
HEART-LUNG TRANSPLANTATION Overall ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
BWGHF Liège Heart transplantation 2008.
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
HEART TRANSPLANTATION Pediatric Recipients JHLT Oct; 32(10):
INTERMACS: June 2006 – December 2012: CMS Report Adults: n=7849 All primary implants as of 12/31/2012 n= 7928 Pediatric patients: n=79 (patients < 19 yrs.
HEART-LUNG TRANSPLANTATION Adult Recipients JHLT Oct; 32(10):
HEART TRANSPLANTATION Pediatric Recipients 2014 JHLT Oct; 33(10):
LUNG TRANSPLANTATION Adult Recipients 2014 JHLT Oct; 33(10):
HEART-LUNG TRANSPLANTATION Pediatric Recipients 2015 JHLT Oct; 34(10):
The Registry of the International Society for Heart and Lung Transplantation: Thirty- second Official Adult Lung and Heart-Lung Transplantation Report—2015;
Evan P. Kransdorf, MD, PhD, Michelle M. Kittleson, MD, PhD, Jignesh K
Volume 150, Issue 2, Pages e6 (February 2016)
The Registry of the International Society for Heart and Lung Transplantation: Twenty- seventh official adult heart transplant report—2010  Josef Stehlik,
Intermacs and the Scientific Registry of Transplant Recipients (SRTR)
Copyright © 2017 American Academy of Pediatrics.
Kaplan-Meier survival for adult heart transplants performed between January 1982 and June 2006 by era. All comparisons are significant at p < (Reproduced.
The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Official Adult Heart Transplant Report—2014; Focus Theme: Retransplantation 
Liver only transplants in the UK Question 2: In terms of survival benefit.
ELSO Registry Data Summary
HEART-LUNG TRANSPLANTATION
HEART TRANSPLANTATION
HEART TRANSPLANTATION
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
LUNG TRANSPLANTATION CURRENT STATUS
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
HEART-LUNG TRANSPLANTATION
Less Is More in Post Pediatric Heart Transplant Care
HEART-LUNG TRANSPLANTATION
HEART TRANSPLANTATION
UK Cystic Fibrosis Registry Annual Data Report 2017
Biostatistics Primer: What a Clinician Ought to Know: Hazard Ratios
Long-Term Outcomes of Critically Ill Adult Allogeneic Hematopoietic Stem Cell Recipients  Prakash Vishnu, Udit Roy, Pramod Guru, Colleen Thomas, Candido.
Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices?  Jeremiah G. Allen, MD, Arman.
HEART-LUNG TRANSPLANTATION
Ruth H. Keogh, Sanja Stanojevic  Journal of Cystic Fibrosis 
Donor Cell Leukemia: A Review
Stephen P. Mcdonald, Graeme R. Russ  Kidney International 
Primary Small Cell Carcinoma of the Esophagus
Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease  Sandra Amaral, Blayne A.
Fig. 1. Kaplan-Meier curves for PFS and OS
Should heart transplantation be considered as a treatment option for patients aged 70 years and older?  Jeffrey A Morgan, MD, Ranjit John, MD, Donna M.
(A). (A). Kaplan-Meier plot of event-free survival in 27 LMNA mutation carriers and 78 DCM control patients. Death, heart transplantation, resuscitation.
Risk factors for primary graft dysfunction after lung transplantation
A: Comparison of pediatric lung transplant survival between different age groups. A: Comparison of pediatric lung transplant survival between different.
HEART-LUNG TRANSPLANTATION
Presentation transcript:

HEART-LUNG TRANSPLANTATION Overall JHLT. 2013 Oct; 32(10): 965-978 2013

Adult and Pediatric Heart-Lung Transplants Number of Transplants Reported by Location and Year NOTE: This figure includes only the heart-lung transplants that are reported to the ISHLT Transplant Registry. As such, this should not be construed as evidence that the number of heart-lung transplants worldwide has declined in recent years. JHLT. 2013 Oct; 32(10): 965-978 2013

Adult and Pediatric Heart-Lung Transplants Average Center Volume (Transplants: January 2000 – June 2012) JHLT. 2013 Oct; 32(10): 965-978 2013

Adult and Pediatric Heart-Lung Transplants Distribution of Transplants by Lung Center Volume (Transplants: January 2000 – June 2012) JHLT. 2013 Oct; 32(10): 965-978 2013

Adult and Pediatric Heart-Lung Transplants Kaplan-Meier Survival for All Ages (Transplants: January 1982 – June 2011) Survival was calculated using the Kaplan-Meier method, which incorporates information from all transplants for whom any follow-up has been provided. Since many patients are still alive and some patients have been lost to follow-up, the survival rates are estimates rather than exact rates because the time of death is not known for all patients. Therefore, 95% confidence limits are provided about the survival rate estimate; the survival rate shown is the best estimate but the true rate will most likely fall within these limits. The median survival is the estimated time point at which 50% of all of the recipients have died. The conditional median survival is the estimated time point at which 50% of the recipients who survive to at least 1 year have died. Because the decline in survival is greatest during the first year following transplantation, the conditional survival provides a more realistic expectation of survival time for recipients who survive the early post-transplant period. JHLT. 2013 Oct; 32(10): 965-978 2013